Owkin
Owkin69
About
What does Owkin do?
Owkin is an AI company focused on solving the complexity of biology to accelerate drug discovery and development. They leverage federated learning and AI to analyze sensitive patient data securely and at scale, enabling better understanding of diseases and identification of new therapeutic targets. Owkin also incubates and spins out companies to bring AI innovations to specific market needs. (formerly ["Owkin Dx"].)
What is Owkin's revenue?
StartupHub estimates Owkin's annual revenue at $67.0M (range $34.9M to $143.6M, 67% confidence), based on comparable companies in the sector.
What is Owkin's valuation?
StartupHub estimates Owkin's effective valuation at $613.7M (range $429.6M to $797.7M, 27% confidence), based on comparable companies in the sector.
How much funding has Owkin raised?
Owkin has raised a total of $80M in funding. The most recent round on record is Series B.
Where is Owkin headquartered?
Owkin is headquartered in New York, New York, USA.
When was Owkin founded?
Owkin was founded in 2016.
What industry does Owkin operate in?
Owkin operates in Artificial Intelligence, Biotechnology, Healthcare, Drug Discovery, Precision Medicine, AI.
How many employees does Owkin have?
Owkin has approximately 250 people on record.
Galatek develops AI-driven automation solutions for life sciences laboratories and advanced semiconductor manufacturing, focusing on precision and reproducibility.
Digital batch record software for pharmaceutical and biotech manufacturing.
Develops and commercializes treatments for central nervous system disorders, including Rett syndrome.
AI-powered platform for peptide design and discovery.
A deep-tech company developing nanorobotic solutions for healthcare, initially targeting dental care applications.
MatrixCode is a research focus at the Freiburg Institute for Advanced Studies (FRIAS) investigating matrisome pathology.
A company focused on privacy, Zcash accumulation, and developing cancer therapeutics.
Biotechnology startup developing next-generation cancer immunotherapies targeting shared tumor-associated antigens.
An entrant is a company tagged Biotechnology whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.